Daniel Jungmyung Oh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniel Jungmyung Oh has a total of 84 co-authors. Here are the top co-authors by number of shared publications:
- Levi Ndiukwu Kanu
Department of Ophthalmology, Schepens Eye Research Institute of Mass Eye and Ear, Harvard Medical School, Boston, USA
7 shared publications Catherine Y. Liu
Department of Ophthalmology, University of California, San Diego
4 shared publicationsJudy L. Chen
Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, IL, USA
3 shared publicationsYi Jiang
Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Chicago, Illinois
3 shared publicationsAhmad A. Aref
Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago
2 shared publicationsEllen Shorter
Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL, USA
2 shared publications
Latest Publications
- Open Access
- 20 April 2023
- Published by Wolters Kluwer Health in Retina
- Vol. 43 (5) , e28-e29
Foveal Development and Posterior Precortical Vitreous Pocket Formation
An abstract is unavailable. This article is available as a PDF only.
- 20 April 2023
- Published by Wolters Kluwer Health in Retina
- Vol. 43 (5) , e28-e29
Open AccessFoveal Development and Posterior Precortical Vitreous Pocket Formation
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 1 June 2020
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 18, 100641
Conjunctival melanoma in an African American man
- 1 June 2020
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 18, 100641
Open AccessConjunctival melanoma in an African American man
- 10 April 2020
- Published by SAGE Publications in Journal of Vitreoretinal Diseases
- Vol. 4 (5) , 437-440
Simplex Crumbs Homologue 1 Maculopathy Masquerading as Juvenile X-Linked Retinoschisis in Male Patients
We demonstrate that Crumbs homologue 1 (CRB1) maculopathy should be considered in the differential of petaloid pigmentary changes in the macula of young children with good vision who may be asymptomatic. We report on 2 unrelated male patients presenting at a young age with decreased vision from a macular dystrophy due to biallelic CRB1 mutations. In addition to a previously described pathogenic variant, Ile167Gly169del, 2 new pathogenic missense variants in CRB1, Thr745Met and Cys948Tyr, are reported here. Although CRB1 mutations have been more commonly described in retinitis pigmentosa and Leber congenital amaurosis, we demonstrate that mutations in CRB1 can cause a maculopathy in which initial features can resemble juvenile X-linked retinoschisis. We show that the accompanying macular edema is responsive to carbonic anhydrase inhibitors. With long-term follow-up for each case, we illustrate the natural history of CRB1 maculopathy based on clinical examination and diagnostic imaging.
- 10 April 2020
- Published by SAGE Publications in Journal of Vitreoretinal Diseases
- Vol. 4 (5) , 437-440
Simplex Crumbs Homologue 1 Maculopathy Masquerading as Juvenile X-Linked Retinoschisis in Male Patients
We demonstrate that Crumbs homologue 1 (CRB1) maculopathy should be considered in the differential of petaloid pigmentary changes in the macula of young children with good vision who may be asymptomatic. We report on 2 unrelated male patients presenting at a young age with decreased vision from a macular dystrophy due to biallelic CRB1 mutations. In addition to a previously described pathogenic variant, Ile167Gly169del, 2 new pathogenic missense variants in CRB1, Thr745Met and Cys948Tyr, are reported here. Although CRB1 mutations have been more commonly described in retinitis pigmentosa and Leber congenital amaurosis, we demonstrate that mutations in CRB1 can cause a maculopathy in which initial features can resemble juvenile X-linked retinoschisis. We show that the accompanying macular edema is responsive to carbonic anhydrase inhibitors. With long-term follow-up for each case, we illustrate the natural history of CRB1 maculopathy based on clinical examination and diagnostic imaging.
- 1 April 2020
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 138 (4) , 358-364
Glaucoma Care of Prison Inmates at an Academic Hospital
Importance Glaucoma care for prison inmates is underrepresented in the literature even though managing the treatment of such patients may provide unique challenges. Objectives To evaluate the glaucoma profile of prison inmates treated at an academic ophthalmology center and to report on the medical and surgical management and follow-up metrics. Design, Setting, and Participants This retrospective cohort study assessed data from 82 incarcerated patients treated at the glaucoma clinic, an academic referral center at the University of Illinois at Chicago, between January 2013 and December 2017. Main Outcomes and Measures Diagnosis, glaucoma severity, medical and surgical interventions, and patient-reported medication adherence were recorded for each visit. Recommended and actual follow-up times were recorded and compared. Data analyses were conducted from January 2013 to December 2018. Results In total, 82 patients (161 eyes) had 375 visits during the study period. All patients were male and ranged from 20 to 75 years of age (mean [SD] age, 50.8 [11.9] years). Most participants were black patients (65 [79.3%]). The most common diagnoses were primary open-angle glaucoma (POAG; 53 eyes [32.9%]) and POAG suspect (52 eyes [32.3%]). Glaucoma severity ranged from mild (25 of 77 eyes [32.5%]) to advanced (41 of 77 eyes [53.2%]). Overall, 59 patients (73.2%) were treated medically with up to 4 topical agents (40.0%). Of those treated, 70.0% of patients (95% CI, 57.7%-81.2%) reported medication nonadherence during at least 1 visit. Medication nonadherence was more common among those taking 4 different topical medications (21 of 24 [87.5%]) compared with others taking fewer medications (20 of 35 [57.1%]), for a difference of 30.4% (95% CI, 7.0%-53.6%;P = .02), and among those with advanced disease (22 of 26 [84.6%]) compared with glaucoma suspect (6 of 13 [46.2%]), for a difference of 38.4% (95% CI, 9.3%-67.5%;P = .02). Nineteen office procedures, including laser peripheral iridotomy and laser trabeculoplasty, were performed on 14 eyes. Seventeen incisional glaucoma procedures were performed on 15 eyes, including glaucoma drainage device implant (11 procedures [64.7%]) and trabeculectomy (3 procedures [17.6%]). Only 26.6% of return office visits (95% CI, 21.3%-32.3%) occurred within the recommended follow-up time frame. Furthermore, 93 patients (34.8%; 95% CI, 28.2%-40.0%) were seen more than 1 month after the recommended follow-up. Conclusions and Relevance Despite incarceration in prison, where medication administration and appointment attendance are theoretically controlled, the results of this study suggested that substantial medication and follow-up nonadherence exists among inmates.
- 1 April 2020
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 138 (4) , 358-364
Glaucoma Care of Prison Inmates at an Academic Hospital
Importance Glaucoma care for prison inmates is underrepresented in the literature even though managing the treatment of such patients may provide unique challenges. Objectives To evaluate the glaucoma profile of prison inmates treated at an academic ophthalmology center and to report on the medical and surgical management and follow-up metrics. Design, Setting, and Participants This retrospective cohort study assessed data from 82 incarcerated patients treated at the glaucoma clinic, an academic referral center at the University of Illinois at Chicago, between January 2013 and December 2017. Main Outcomes and Measures Diagnosis, glaucoma severity, medical and surgical interventions, and patient-reported medication adherence were recorded for each visit. Recommended and actual follow-up times were recorded and compared. Data analyses were conducted from January 2013 to December 2018. Results In total, 82 patients (161 eyes) had 375 visits during the study period. All patients were male and ranged from 20 to 75 years of age (mean [SD] age, 50.8 [11.9] years). Most participants were black patients (65 [79.3%]). The most common diagnoses were primary open-angle glaucoma (POAG; 53 eyes [32.9%]) and POAG suspect (52 eyes [32.3%]). Glaucoma severity ranged from mild (25 of 77 eyes [32.5%]) to advanced (41 of 77 eyes [53.2%]). Overall, 59 patients (73.2%) were treated medically with up to 4 topical agents (40.0%). Of those treated, 70.0% of patients (95% CI, 57.7%-81.2%) reported medication nonadherence during at least 1 visit. Medication nonadherence was more common among those taking 4 different topical medications (21 of 24 [87.5%]) compared with others taking fewer medications (20 of 35 [57.1%]), for a difference of 30.4% (95% CI, 7.0%-53.6%;P = .02), and among those with advanced disease (22 of 26 [84.6%]) compared with glaucoma suspect (6 of 13 [46.2%]), for a difference of 38.4% (95% CI, 9.3%-67.5%;P = .02). Nineteen office procedures, including laser peripheral iridotomy and laser trabeculoplasty, were performed on 14 eyes. Seventeen incisional glaucoma procedures were performed on 15 eyes, including glaucoma drainage device implant (11 procedures [64.7%]) and trabeculectomy (3 procedures [17.6%]). Only 26.6% of return office visits (95% CI, 21.3%-32.3%) occurred within the recommended follow-up time frame. Furthermore, 93 patients (34.8%; 95% CI, 28.2%-40.0%) were seen more than 1 month after the recommended follow-up. Conclusions and Relevance Despite incarceration in prison, where medication administration and appointment attendance are theoretically controlled, the results of this study suggested that substantial medication and follow-up nonadherence exists among inmates.
- Open Access
- 1 March 2020
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 17, 100601
Scleral lens for severe dry eye status post lacrimal gland resection for adenoid cystic carcinoma
- 1 March 2020
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 17, 100601
Open AccessScleral lens for severe dry eye status post lacrimal gland resection for adenoid cystic carcinoma
- 1 November 2019
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 137 (11) , 1321-1322
A Woman With Bilateral Retinal Detachments
A 33-year-old black woman presents with bilateral retinal detachments after a flulike illness. Fundus and B-scan ultrasonographic examinations reveal several ab
- 1 November 2019
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 137 (11) , 1321-1322
A Woman With Bilateral Retinal Detachments
A 33-year-old black woman presents with bilateral retinal detachments after a flulike illness. Fundus and B-scan ultrasonographic examinations reveal several ab
- 1 October 2019
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 137 (10) , 1203-1204
An 81-Year-Old Man With Multifocal Choroidal Lesions
- 1 October 2019
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 137 (10) , 1203-1204
An 81-Year-Old Man With Multifocal Choroidal Lesions
- Open Access
- 22 August 2019
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
- Vol. 39 (9) , NP398-NP402
A Lazy-T Modification in the Treatment of Medial Ectropion
Involutional ectropion, caused by horizontal and vertical eyelid laxity and variable stretching or disinsertion of the capsulopalpebral fascia, can be surgically corrected by a number of methods.1 The lazy-T technique, described by Byron Smith in 1976,2 is a good option for ectropion repair predominantly in the medial portion of the lower lid. Horizontal and vertical eyelid shortening is achieved by full thickness excision of a portion of the lower lid as well as the posterior lamella in a sideways “T” configuration.2
- 22 August 2019
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
- Vol. 39 (9) , NP398-NP402
Open AccessA Lazy-T Modification in the Treatment of Medial Ectropion
Involutional ectropion, caused by horizontal and vertical eyelid laxity and variable stretching or disinsertion of the capsulopalpebral fascia, can be surgically corrected by a number of methods.1 The lazy-T technique, described by Byron Smith in 1976,2 is a good option for ectropion repair predominantly in the medial portion of the lower lid. Horizontal and vertical eyelid shortening is achieved by full thickness excision of a portion of the lower lid as well as the posterior lamella in a sideways “T” configuration.2
- 1 July 2019
- Published by Elsevier in Ophthalmology Retina
- Vol. 3 (7) , 579
Inadvertent Globe Penetration with Posterior Sub-Tenon Triamcinolone Injection and Subsequent Laser Barricade
- 1 July 2019
- Published by Elsevier in Ophthalmology Retina
- Vol. 3 (7) , 579
Inadvertent Globe Penetration with Posterior Sub-Tenon Triamcinolone Injection and Subsequent Laser Barricade
- 1 July 2019
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 137 (7) , 842-843
A Man With a Large Conjunctival Lesion
A 27-year-old man presented to the clinic for evaluation of a painless, red mass in his right eye present since birth. What would you do next?
- 1 July 2019
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 137 (7) , 842-843
A Man With a Large Conjunctival Lesion
A 27-year-old man presented to the clinic for evaluation of a painless, red mass in his right eye present since birth. What would you do next?